Ex Parte Shannon - Page 7

               Appeal  2007-1998                                                                            
               Application 09/997,829                                                                       
                      Michal teaches a stent with coating comprising a base coat and a top                  
               coat, wherein the top coat comprises a therapeutic agent (Michal, col. 2, ll.                
               13-14 and 28-29).  In an alternative, Michal teaches the application of a                    
               therapeutic coating directly to the stent (Michal, col. 5, ll. 42-44).                       
               Nevertheless, in each instance Michal’s therapeutic coating is the outermost                 
               layer.  Neither the Examiner nor Michal provide a reason why a person of                     
               ordinary skill in the art would add an additional layer, e.g., a tubular outer               
               layer comprising expanded, sintered PTFE tape, on top of the therapeutic                     
               coating.  Prima facie obviousness requires a teaching that all elements of the               
               claimed invention are found in the prior art and a reason that would have                    
               prompted a person of ordinary skill in the relevant field to modify the prior                
               art to arrive at the claimed invention.  See KSR, 127 S. Ct. at 1741, 82                     
               USPQ2d at 1396.  Accordingly, Michal fails to make up for the deficiency in                  
               the combination of Myers and Choi.                                                           
                      On reflection, we find that the evidence of record is insufficient                    
               to support a prima facie case of obviousness.  Accordingly, we reverse                       
               the rejection of claim 106 under 35 U.S.C § 103(a) as unpatentable                           
               over the combination of Myers, Choi, and Michal.                                             

               3.  Claims 108-111 stand rejected under 35 U.S.C. § 103(a) as unpatentable                   
               over the combination of Myers, Choi, and Wijay.  Claims 108-111 depend                       
               directly or indirectly from claim 103.                                                       
                      The Examiner relies on the combination of Myers and Choi as set                       
               forth above (Answer 6).  The Examiner finds that the combination of Myers                    
               and Choi fail to teach a non-foreshortening stent (id.).  The Examiner relies                
               on Wijay to teach stents “having a plurality of undulating elements with at                  

                                                     7                                                      

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next

Last modified: September 9, 2013